Clinical Trials Browser

Phase 1 × Lymphoma, Non-Hodgkin × milatuzumab × Clear all

NCT00504972 2018-05-29

Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies

Phase 1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell